Campbell & CO Investment Adviser LLC Ideaya Biosciences, Inc. Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$34.37 - $43.46 $953,251 - $1.21 Million
-27,735 Reduced 52.76%
24,834 $871,000
Q1 2024

May 10, 2024
SELL
$34.2 - $47.13 $296,069 - $408,004
-8,657 Reduced 14.14%
52,569 $2.31 Million
Q4 2023

Feb 13, 2024
BUY
$24.59 - $35.83 $726,290 - $1.06 Million
29,536 Added 93.2%
61,226 $2.18 Million
Q3 2023

Nov 08, 2023
BUY
$21.07 - $29.77 $221,361 - $312,763
10,506 Added 49.59%
31,690 $854,000
Q2 2023

Aug 11, 2023
BUY
$13.33 - $25.53 $282,382 - $540,827
21,184 New
21,184 $497,000

Others Institutions Holding IDYA

# of Institutions
216
Shares Held
80.8M
Call Options Held
69K
Put Options Held
20K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.31B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email